Vanda Pharmaceuticals | Kortsiktig Gjeld

Current Liabilities Endring Dato
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Agios Pharmaceuticals USD 67.96M 9.53M 2023-12
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
Arrowhead Research USD 63.72M 41.73M 2023-12
AstraZeneca USD 28.59B 2.21B 2023-09
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Halozyme Therapeutics USD 112.49M 2.69M 2023-12
Insmed USD 225.63M 28.9M 2023-12
Ligand Pharmaceuticals USD 16.78M 1.06M 2023-12
Merck USD 23.09B 300M 2023-09
Moderna USD 3.02B 1.37B 2023-12
Pfizer USD 31.14B 3.51B 2023-09
PTC Therapeutics USD 603.1M 110.98M 2023-12
Takeda JPY 2.37T 134.12B 2023-09
Teva Pharmaceutical Industries USD 11.39B 449M 2023-09
Ultragenyx Pharmaceutical USD 253.98M 9.6M 2023-09
Veracyte USD 61.24M 3.98M 2023-12



Vanda Pharmaceuticals Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.